Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Performance of Novel Kidney Biomarkers in Preclinical Toxicity Studies

Hoffmann, D and Adler, M and Clement, M and Vaidya, V and Rached, E and Mulrane, L and Gallagher,, WM and Callanan, JJ and Gautier, JC and Matheis, K and Staedtler, Frank and Dieterle, Frank and Walijew, A and Hewitt, P and Ellinger-Ziegelbauer, H and Bonventre, JV and Dekant, W and Mally, A (2010) Performance of Novel Kidney Biomarkers in Preclinical Toxicity Studies. Toxicological Sciences, 116 (1). pp. 8-22.

Abstract

The kidney is one of the main targets of drug toxicity, but early detection of renal damage is often difficult. As part of the InnoMed PredTox project, a collaborative effort aimed at assessing the value of combining omics technologies with conventional toxicology methods for improved preclinical safety assessment, we evaluated the performance of a panel of novel kidney biomarkers in preclinical toxicity studies. Rats were treated with a reference nephrotoxin or one of several proprietary compounds that were dropped from drug development in part due to renal toxicity. Animals were dosed at two dose levels for 1, 3, and 14 days. Putative kidney markers, including kidney injury molecule-1 (Kim-1), lipocalin-2 (Lcn2), clusterin, and tissue inhibitor of metalloproteinases-1, were analyzed in kidney and urine using quantitative real-time PCR, ELISA, and immunohistochemistry. Changes in gene/protein expression generally correlated well with renal histopathological alterations and were frequently detected at earlier time points or at lower doses than the traditional clinical parameters blood urea nitrogen and serum creatinine. Urinary Kim-1 and clusterin reflected changes in gene/protein expression and histopathological alterations in the target organ in the absence of functional changes. This confirms clusterin and Kim-1 as early and sensitive, noninvasive markers of renal injury. Although Lcn2 did not appear to be specific for kidney toxicity, its rapid response to inflammation and tissue damage in general may suggest its utility in routine toxicity testing.

Item Type: Article
Related URLs:
Keywords: Kidney, drug-induced nephrotoxicity, biomarker, Kim-1, clusterin, lipocalin-2
Related URLs:
Date Deposited: 13 Oct 2015 13:17
Last Modified: 13 Oct 2015 13:17
URI: https://oak.novartis.com/id/eprint/1272

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.